Cargando…

Using the aMAP Risk Score to Predict Late Recurrence Following Radiofrequency Ablation for Hepatocellular Carcinoma in Chinese Population: A Multicenter Study

OBJECTIVE: This study was conducted to explore the application of age-male-ALBI-platelets (aMAP) score for predicting late recurrence of hepatocellular carcinoma (HCC) following radiofrequency ablation (RFA) and develop an aMAP score based-nomogram to predict prognosis in Chinese population. MATERIA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yi, Zhou, Yanzhao, Zhang, Xinyuan, Xin, Yujing, Chen, Yi, Fan, Qingsheng, Li, Xiao, Wei, Xi, Li, Qiang, Zhou, Xiang, Zhou, Jinxue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8327363/ https://www.ncbi.nlm.nih.gov/pubmed/34350139 http://dx.doi.org/10.2147/JHC.S308587

Ejemplares similares

Challenges Facing Percutaneous Ablation in the Treatment of Hepatocellular Carcinoma: Extension of Ablation Criteria
por: Zhou, Yanzhao, et al.
Publicado: (2021)

Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify
por: Johnson, Philip J., et al.
Publicado: (2022)

Usefulness of aMAP Risk Score for Predicting Recurrence after Curative Treatment for Hepatocellular Carcinoma within Milan Criteria
por: Ohama, Hideko, et al.
Publicado: (2023)

Validation of the hepatocellular carcinoma early detection screening algorithm Doylestown and aMAP in a cohort of Chinese with cirrhosis
por: Qian, Yunsong, et al.
Publicado: (2022)

The aMAP Score is an Independent Risk Factor for Intermediate-stage Hepatocellular Carcinoma: A Large Retrospective Cohort Study
por: Chen, Yaying, et al.
Publicado: (2023)

Recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: Analysis of the pattern and risk factors
por: Chen, Rui, et al.
Publicado: (2023)

External Validation of aMAP Hepatocellular Carcinoma Risk Score in Patients With Chronic Hepatitis B-Related Cirrhosis Receiving ETV or TDF Therapy
por: Gui, Honglian, et al.
Publicado: (2021)

aMAP Score as a Predictor for Long-Term Outcomes in Patients with HBV-Related Acute-on-Chronic Liver Failure
por: Sun, Yunqing, et al.
Publicado: (2022)

Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysis
por: Zhou, Qunfang, et al.
Publicado: (2022)

Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
por: Xin, Yujing, et al.
Publicado: (2022)

Correction to: Sorafenib as adjuvant therapy following radiofrequency ablation for recurrent hepatocellular carcinoma within Milan criteria: a multicenter analysis
por: Zhou, Qunfang, et al.
Publicado: (2022)

Small single perivascular hepatocellular carcinoma: comparisons of radiofrequency ablation and microwave ablation by using propensity score analysis
por: An, Chao, et al.
Publicado: (2021)

AMAP assessment 2015: human health in the Arctic
por: Odland, Jon Øyvind, et al.
Publicado: (2016)

Efficacy of microwave ablation versus radiofrequency ablation for hepatocellular carcinoma: a propensity score analysis
por: Suwa, Kanehiko, et al.
Publicado: (2021)

Oncological Effects and Prognostic Value of AMAP1 in Gastric Cancer
por: Li, Jiao, et al.
Publicado: (2021)

Surgical Resection plus Radiofrequency Ablation versus Radical Surgery for Hepatocellular Carcinoma: A Propensity Score Matching Analysis
por: Zhou, Cheng, et al.
Publicado: (2019)

Laparoscopic radiofrequency ablation versus percutaneous radiofrequency ablation for subphrenic hepatocellular carcinoma
por: Kwak, Min Hwan, et al.
Publicado: (2022)

The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma
por: Xu, Zhentian, et al.
Publicado: (2019)

Adjuvant Lenvatinib Plus PD-1 Antibody for Hepatocellular Carcinoma with High Recurrence Risks After Hepatectomy: A Retrospective Landmark Analysis
por: Ouyang, Jingzhong, et al.
Publicado: (2023)

aMAP is a validated pipeline for registration and segmentation of high-resolution mouse brain data
por: Niedworok, Christian J., et al.
Publicado: (2016)

Radiofrequency Ablation Versus Reresection in Treating Recurrent Hepatocellular Carcinoma: A Meta-Analysis
por: Cai, Hao, et al.
Publicado: (2014)

Radiofrequency Thermal Ablation of Hepatocellular Carcinomas
por: Lim, Hyo Keun
Publicado: (2000)

Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma
por: Zhou, Yanming, et al.
Publicado: (2010)

Treatment optimization for recurrent hepatocellular carcinoma: Repeat hepatic resection versus radiofrequency ablation
por: Lu, Liang‐He, et al.
Publicado: (2020)

Surgical Resection or Radiofrequency Ablation for Small Hepatocellular Carcinoma
por: Feng, Qingbo, et al.
Publicado: (2022)

Aggressive tumor recurrence after radiofrequency ablation for hepatocellular carcinoma
por: Kang, Tae Wook, et al.
Publicado: (2017)

An efficient cardiac mapping strategy for radiofrequency catheter ablation with active learning
por: Feng, Yingjing, et al.
Publicado: (2017)

Stereotactic Body Radiotherapy as a Salvage Therapy after Incomplete Radiofrequency Ablation for Hepatocellular Carcinoma: A Retrospective Propensity Score Matching Study
por: Pan, Yang-Xun, et al.
Publicado: (2019)

Liver resection versus radiofrequency ablation for hepatitis B virus-related small hepatocellular carcinoma
por: Liang, Bin, et al.
Publicado: (2018)

Prediction of very late arrhythmia recurrence after radiofrequency catheter ablation of atrial fibrillation: The MB-LATER clinical score
por: Mujović, Nebojša, et al.
Publicado: (2017)

Comparisons of Radiofrequency Ablation, Microwave Ablation, and Irreversible Electroporation by Using Propensity Score Analysis for Early Stage Hepatocellular Carcinoma
por: Wada, Takuya, et al.
Publicado: (2023)

Predicting Late Recurrence of Atrial Fibrillation After Radiofrequency Ablation in Patients With Atrial Fibrillation: Comparison of C2HEST and HATCH Scores
por: Han, Jingjing, et al.
Publicado: (2022)

Late-onset diaphragmatic hernia after percutaneous radiofrequency ablation of hepatocellular carcinoma: a case study
por: Abe, Tomoyuki, et al.
Publicado: (2016)

Percutaneous Radiofrequency Ablation with or without Chemolipiodolization for Hepatocellular Carcinoma: A Propensity-Score-Matched Analysis
por: Takaki, Kota, et al.
Publicado: (2022)

Meta-analysis of surgical resection and radiofrequency ablation for early hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2012)

Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinoma
por: Duan, Feng, et al.
Publicado: (2020)

Microwave ablation versus radiofrequency ablation for the treatment of pulmonary tumors
por: Shi, Feng, et al.
Publicado: (2017)

Use of radiofrequency ablation in the treatment of hepatocellular carcinoma: Experience of ablation protocols
por: MASAYOSHI, TAKAHASHI, et al.
Publicado: (2012)

Adaptive ultrasound temperature imaging for monitoring radiofrequency ablation
por: Liu, Yi-Da, et al.
Publicado: (2017)

Effects of radiofrequency ablation versus other ablating techniques on hepatocellular carcinomas: a systematic review and meta-analysis
por: Luo, Wen, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vl5323p4oopn8leb54rm3nk267